Christina Messiou

Fulham Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 190 publications

Global Consensus on the Management of Primary Localized Chordoma.

Global Consensus on the Management of Primary Localized Chordoma.

Journal: JAMA oncology

Published: July 09, 2026

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

Journal: Haematologica

Published: June 06, 2026

AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

Journal: Blood advances

Published: April 30, 2026

Precision medicine in myeloma demands precision imaging: is whole body MRI the solution?

Precision medicine in myeloma demands precision imaging: is whole body MRI the solution?

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: March 12, 2026

Improving patient understanding of oncology imaging: radiologist and patient evaluation of summarised versus full-length AI-simplified reports from a tertiary cancer centre.

Improving patient understanding of oncology imaging: radiologist and patient evaluation of summarised versus full-length AI-simplified reports from a tertiary cancer centre.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: February 04, 2026

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

Journal: Radiography (London, England : 1995)

Published: January 28, 2026

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: December 03, 2025

Patient-Specific Biases in Fat Fraction Estimates of Malignant Bone Marrow due to Relaxation Times Measured With STEAM at 3T.

Patient-Specific Biases in Fat Fraction Estimates of Malignant Bone Marrow due to Relaxation Times Measured With STEAM at 3T.

Journal: NMR in biomedicine

Published: September 29, 2025

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 07, 2025

Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107].

Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107].

Journal: Academic radiology

Published: July 12, 2025

Targeted magnetic resonance imagings (MRIs) inform clinical management in biochemically stable multiple myeloma patients presenting with new pain.

Targeted magnetic resonance imagings (MRIs) inform clinical management in biochemically stable multiple myeloma patients presenting with new pain.

Journal: Clinical radiology

Published: June 20, 2025

A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST).

A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST).

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 28, 2025

Showing 1-12 of 190

Last Updated: 09/26/2026